 SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 GLOBE NEWSWIRE -- Calithera Biosciences, Inc. Nasdaq: CALA, a fully-integrated clinical stage biotechnology company focused on discovering and developing novel, small molecule drugs for the treatment of cancer and other life-threatening diseases, announced today its participation in two upcoming virtual healthcare investor conferences. 